Critical appraisal of bepotastine in the treatment of ocular itching associated with allergic conjunctivitis

Jeremy B Wingard, Francis S MahUPMC Eye Center, Department of Ophthalmology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USAAbstract: Bepotastine besilate 1.5% solution is an H1-antihistamine recently approved by the Food and Drug Administration for the topical treatment of ocular i...

Full description

Saved in:

Bibliographic Details
Main Authors:	Jeremy B Wingard, Francis S Mah
Format:	article
Language:	EN
Published:	Dove Medical Press 2011
Subjects:	Ophthalmology RE1-994
Online Access:	https://doaj.org/article/19e368d1c9334adc98c1108334b34dd1
Tags:	Add Tag No Tags, Be the first to tag this record!

id	oai:doaj.org-article:19e368d1c9334adc98c1108334b34dd1
record_format	dspace
spelling	oai:doaj.org-article:19e368d1c9334adc98c1108334b34dd12021-12-02T09:46:34ZCritical appraisal of bepotastine in the treatment of ocular itching associated with allergic conjunctivitis1177-54671177-5483https://doaj.org/article/19e368d1c9334adc98c1108334b34dd12011-02-01T00:00:00Zhttp://www.dovepress.com/critical-appraisal-of-bepotastine-in-the-treatment-of-ocular-itching-a-a6345https://doaj.org/toc/1177-5467https://doaj.org/toc/1177-5483Jeremy B Wingard, Francis S MahUPMC Eye Center, Department of Ophthalmology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USAAbstract: Bepotastine besilate 1.5% solution is an H1-antihistamine recently approved by the Food and Drug Administration for the topical treatment of ocular itching associated with allergic conjunctivitis. Several clinical studies have demonstrated its safety as well as its efficacy versus placebo. This review finds that bepotastine besilate 1.5% solution is a suitable alternative to other agents within the class of H1-antihistamines, but there are no clinical trial data to suggest that it holds any specific advantages over other agents.Keywords: allergic conjunctivitis, antihistamine, ocular itching Jeremy B WingardFrancis S MahDove Medical PressarticleOphthalmologyRE1-994ENClinical Ophthalmology, Vol 2011, Iss default, Pp 201-207 (2011)
institution	DOAJ
collection	DOAJ
language	EN
topic	Ophthalmology RE1-994
spellingShingle	Ophthalmology RE1-994 Jeremy B Wingard Francis S Mah Critical appraisal of bepotastine in the treatment of ocular itching associated with allergic conjunctivitis
description	Jeremy B Wingard, Francis S MahUPMC Eye Center, Department of Ophthalmology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USAAbstract: Bepotastine besilate 1.5% solution is an H1-antihistamine recently approved by the Food and Drug Administration for the topical treatment of ocular itching associated with allergic conjunctivitis. Several clinical studies have demonstrated its safety as well as its efficacy versus placebo. This review finds that bepotastine besilate 1.5% solution is a suitable alternative to other agents within the class of H1-antihistamines, but there are no clinical trial data to suggest that it holds any specific advantages over other agents.Keywords: allergic conjunctivitis, antihistamine, ocular itching
format	article
author	Jeremy B Wingard Francis S Mah
author_facet	Jeremy B Wingard Francis S Mah
author_sort	Jeremy B Wingard
title	Critical appraisal of bepotastine in the treatment of ocular itching associated with allergic conjunctivitis
title_short	Critical appraisal of bepotastine in the treatment of ocular itching associated with allergic conjunctivitis
title_full	Critical appraisal of bepotastine in the treatment of ocular itching associated with allergic conjunctivitis
title_fullStr	Critical appraisal of bepotastine in the treatment of ocular itching associated with allergic conjunctivitis
title_full_unstemmed	Critical appraisal of bepotastine in the treatment of ocular itching associated with allergic conjunctivitis
title_sort	critical appraisal of bepotastine in the treatment of ocular itching associated with allergic conjunctivitis
publisher	Dove Medical Press
publishDate	2011
url	https://doaj.org/article/19e368d1c9334adc98c1108334b34dd1
work_keys_str_mv	AT jeremybwingard criticalappraisalofbepotastineinthetreatmentofocularitchingassociatedwithallergicconjunctivitis AT francissmah criticalappraisalofbepotastineinthetreatmentofocularitchingassociatedwithallergicconjunctivitis
_version_	1718397991313735680

Critical appraisal of bepotastine in the treatment of ocular itching associated with allergic conjunctivitis

Similar Items